• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎合并间质性肺炎患者冠状动脉钙化的预后价值:一项病例对照研究

Prognostic Value of Coronary Artery Calcification in Patients with COVID-19 and Interstitial Pneumonia: A Case-Control Study.

作者信息

Dall'Ara Gianni, Piciucchi Sara, Carletti Roberto, Vizzuso Antonio, Gardini Elisa, De Vita Maria, Dallaserra Chiara, Campacci Federica, Di Giannuario Giovanna, Grosseto Daniele, Rinaldi Giovanni, Vecchio Sabine, Mantero Federica, Mellini Lorenzo, Albini Alessandra, Giampalma Emanuela, Poletti Venerino, Galvani Marcello

机构信息

Cardiology Unit, Morgagni-Pierantoni Hospital, 47121 Forlì, Italy.

Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 47121 Forlì, Italy.

出版信息

J Cardiovasc Dev Dis. 2024 Oct 11;11(10):319. doi: 10.3390/jcdd11100319.

DOI:10.3390/jcdd11100319
PMID:39452289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11508648/
Abstract

Patients suffering from coronavirus disease-19 (COVID-19)-related interstitial pneumonia have variable outcomes, and the risk factors for a more severe course have yet to be comprehensively identified. Cohort studies have suggested that coronary artery calcium (CAC), as estimated at chest computed tomography (CT) scan, correlated with patient outcomes. However, given that the prevalence of CAC is gender- and age-dependent, the influence of baseline confounders cannot be completely excluded. We designed a retrospective, multicenter case-control study including patients with COVID-19, with severe course cases selected based on death within 30 days or requiring invasive ventilation, whereas controls were age- and sex-matched patients surviving up to 30 days without invasive ventilation. The primary outcome was the analysis of moderate-to-severe CAC prevalence between cases and controls. A total of 65 cases and 130 controls were included in the study. Cases had a significantly higher median pulmonary severity score at chest CT scan compared to controls (10 vs. 8, respectively; = 0.0001), as well as a higher CAC score (5 vs. 2; = 0.009). The prevalence of moderate-to-severe CAC in cases was significantly greater (41.5% vs. 23.8%; = 0.013), a difference mainly driven by a higher prevalence in those who died within 30 days ( = 0.000), rather than those requiring invasive ventilation ( = 0.847). White blood cell count, moderate-to-severe CAC, the need for antibiotic therapy, and severe pneumonia at CT scan were independent primary endpoint predictors. This case-control study demonstrated that the CAC burden was higher in COVID-19 patients who did not survive 30 days or who required mechanical ventilation, and CAC played an independent prognostic role.

摘要

患有新型冠状病毒肺炎(COVID-19)相关间质性肺炎的患者预后各不相同,而病情更严重的危险因素尚未得到全面识别。队列研究表明,胸部计算机断层扫描(CT)估算的冠状动脉钙化(CAC)与患者预后相关。然而,鉴于CAC的患病率与性别和年龄有关,基线混杂因素的影响不能完全排除。我们设计了一项回顾性、多中心病例对照研究,纳入COVID-19患者,严重病例根据30天内死亡或需要有创通气来选择,而对照组为年龄和性别匹配、存活30天且无需有创通气的患者。主要结局是分析病例组和对照组中中重度CAC的患病率。该研究共纳入65例病例和130例对照。与对照组相比,病例组胸部CT扫描时的中位肺部严重程度评分显著更高(分别为10和8;P = 0.0001),CAC评分也更高(5和2;P = 0.009)。病例组中重度CAC的患病率显著更高(41.5%对23.8%;P = 0.013),这种差异主要由30天内死亡者的较高患病率所致(P = 0.000),而非需要有创通气者(P = 0.847)。白细胞计数、中重度CAC、抗生素治疗需求以及CT扫描显示的重症肺炎是独立的主要终点预测因素。这项病例对照研究表明,在未存活30天或需要机械通气的COVID-19患者中,CAC负担更高,且CAC发挥了独立的预后作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1f/11508648/b6d8ab392c47/jcdd-11-00319-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1f/11508648/6db83e4f3229/jcdd-11-00319-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1f/11508648/6020af7d3aee/jcdd-11-00319-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1f/11508648/b5f8a3d1c31e/jcdd-11-00319-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1f/11508648/b6d8ab392c47/jcdd-11-00319-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1f/11508648/6db83e4f3229/jcdd-11-00319-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1f/11508648/6020af7d3aee/jcdd-11-00319-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1f/11508648/b5f8a3d1c31e/jcdd-11-00319-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1f/11508648/b6d8ab392c47/jcdd-11-00319-g004.jpg

相似文献

1
Prognostic Value of Coronary Artery Calcification in Patients with COVID-19 and Interstitial Pneumonia: A Case-Control Study.新型冠状病毒肺炎合并间质性肺炎患者冠状动脉钙化的预后价值:一项病例对照研究
J Cardiovasc Dev Dis. 2024 Oct 11;11(10):319. doi: 10.3390/jcdd11100319.
2
Lung Opacity and Coronary Artery Calcium Score: A Combined Tool for Risk Stratification and Outcome Prediction in COVID-19 Patients.肺部混浊与冠状动脉钙化评分:COVID-19患者风险分层和预后预测的联合工具
Acad Radiol. 2022 Jun;29(6):861-870. doi: 10.1016/j.acra.2022.02.019. Epub 2022 Feb 28.
3
In-hospital prognostic role of coronary atherosclerotic burden in COVID-19 patients.冠状动脉粥样硬化负荷在COVID-19患者中的院内预后作用。
J Cardiovasc Med (Hagerstown). 2021 Nov 1;22(11):818-827. doi: 10.2459/JCM.0000000000001228.
4
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
5
Machine learning-based coronary artery calcium score predicted from clinical variables as a prognostic indicator in patients referred for invasive coronary angiography.基于机器学习的冠状动脉钙评分可从临床变量预测,在接受有创冠状动脉造影的患者中作为预后指标。
Eur Radiol. 2024 Sep;34(9):5633-5643. doi: 10.1007/s00330-024-10629-3. Epub 2024 Feb 10.
6
Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19.新冠肺炎患者冠状动脉钙评估的临床和亚临床冠状动脉疾病的影响。
Atherosclerosis. 2021 Jul;328:136-143. doi: 10.1016/j.atherosclerosis.2021.03.041. Epub 2021 Apr 7.
7
Coronary artery calcifications and 6-month mortality in patients with COVID-19 without known atheromatous disease.COVID-19 无已知动脉粥样硬化疾病患者的冠状动脉钙化与 6 个月死亡率。
Arch Cardiovasc Dis. 2022 May;115(5):276-287. doi: 10.1016/j.acvd.2022.02.007. Epub 2022 Mar 4.
8
Coronary artery calcification score as a prognostic indicator for COVID-19 mortality: evidence from a retrospective cohort study in Iran.冠状动脉钙化评分作为COVID-19死亡率的预后指标:来自伊朗一项回顾性队列研究的证据。
Ann Med Surg (Lond). 2024 Apr 4;86(6):3227-3232. doi: 10.1097/MS9.0000000000001661. eCollection 2024 Jun.
9
Association of coronary calcification with prognosis of Covid-19 patients without known heart disease.冠状动脉钙化与无已知心脏病的 COVID-19 患者预后的关系。
Braz J Med Biol Res. 2021 Dec 3;54(12):e11681. doi: 10.1590/1414-431X2021e11681. eCollection 2021.
10
Coronary artery calcification and risk of mortality and adverse outcomes in patients with COVID-19: a Chinese multicenter retrospective cohort study.新冠病毒肺炎患者冠状动脉钙化与死亡及不良结局风险:一项中国多中心回顾性队列研究
Chin J Acad Radiol. 2022;5(1):20-28. doi: 10.1007/s42058-021-00072-4. Epub 2021 Jun 28.

本文引用的文献

1
The association between coronary artery calcification and vectorcardiography in mechanically ventilated COVID-19 patients: the Maastricht Intensive Care COVID cohort.机械通气的新冠肺炎患者冠状动脉钙化与向量心电图的关联:马斯特里赫特重症监护新冠肺炎队列研究
Intensive Care Med Exp. 2024 Mar 7;12(1):26. doi: 10.1186/s40635-024-00611-0.
2
COVID-19 and cardiovascular complications: updates of emergency medicine.新型冠状病毒肺炎与心血管并发症:急诊医学的最新进展
Emerg Crit Care Med. 2023 Sep;3(3):104-114. doi: 10.1097/ec9.0000000000000095. Epub 2023 Jun 1.
3
CT coronary artery calcification score as a prognostic marker in COVID-19.
CT冠状动脉钙化评分作为COVID-19的预后标志物
J Thorac Dis. 2023 Oct 31;15(10):5559-5565. doi: 10.21037/jtd-23-728. Epub 2023 Oct 20.
4
Correlation between Coronary Artery Disease with Other Arterial Systems: Similar, Albeit Separate, Underlying Pathophysiologic Mechanisms.冠状动脉疾病与其他动脉系统之间的关联:尽管各自独立,但存在相似的潜在病理生理机制。
J Cardiovasc Dev Dis. 2023 May 11;10(5):210. doi: 10.3390/jcdd10050210.
5
Coronary artery calcification as a predictor of adverse outcomes in patients hospitalized with COVID-19.冠状动脉钙化作为新冠病毒疾病住院患者不良结局的预测指标。
Am Heart J Plus. 2023 Apr;28:100288. doi: 10.1016/j.ahjo.2023.100288. Epub 2023 Mar 8.
6
Idiopathic pulmonary fibrosis is more strongly associated with coronary artery disease than chronic obstructive pulmonary disease.特发性肺纤维化与冠状动脉疾病的相关性强于慢性阻塞性肺疾病。
Respir Med. 2023 May;211:107195. doi: 10.1016/j.rmed.2023.107195. Epub 2023 Mar 6.
7
Comorbidities, multimorbidity and COVID-19.合并症、多重疾病与2019冠状病毒病
Nat Med. 2023 Feb;29(2):334-343. doi: 10.1038/s41591-022-02156-9. Epub 2023 Feb 16.
8
Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence.全身性皮质类固醇治疗 COVID-19:与公平相关的分析和证据更新。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD014963. doi: 10.1002/14651858.CD014963.pub2.
9
Review article: obesity and colorectal cancer.综述文章:肥胖与结直肠癌。
Aliment Pharmacol Ther. 2022 Aug;56(3):407-418. doi: 10.1111/apt.17045. Epub 2022 Jun 16.
10
Radial Artery Calcification in Predicting Coronary Calcification and Atherosclerosis Burden.桡动脉钙化在预测冠状动脉钙化和动脉粥样硬化负担中的作用
Cardiol Res Pract. 2022 May 31;2022:5108389. doi: 10.1155/2022/5108389. eCollection 2022.